1. Home
  2. OVID vs GCV Comparison

OVID vs GCV Comparison

Compare OVID & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • GCV
  • Stock Information
  • Founded
  • OVID 2014
  • GCV 1988
  • Country
  • OVID United States
  • GCV United States
  • Employees
  • OVID N/A
  • GCV N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • GCV Finance/Investors Services
  • Sector
  • OVID Health Care
  • GCV Finance
  • Exchange
  • OVID Nasdaq
  • GCV Nasdaq
  • Market Cap
  • OVID 88.9M
  • GCV 84.3M
  • IPO Year
  • OVID 2017
  • GCV N/A
  • Fundamental
  • Price
  • OVID $1.72
  • GCV $4.25
  • Analyst Decision
  • OVID Strong Buy
  • GCV
  • Analyst Count
  • OVID 4
  • GCV 0
  • Target Price
  • OVID $3.13
  • GCV N/A
  • AVG Volume (30 Days)
  • OVID 5.1M
  • GCV 57.9K
  • Earning Date
  • OVID 11-11-2025
  • GCV 01-01-0001
  • Dividend Yield
  • OVID N/A
  • GCV 13.04%
  • EPS Growth
  • OVID N/A
  • GCV N/A
  • EPS
  • OVID N/A
  • GCV N/A
  • Revenue
  • OVID $6,651,000.00
  • GCV N/A
  • Revenue This Year
  • OVID $1,086.57
  • GCV N/A
  • Revenue Next Year
  • OVID N/A
  • GCV N/A
  • P/E Ratio
  • OVID N/A
  • GCV N/A
  • Revenue Growth
  • OVID 1070.95
  • GCV N/A
  • 52 Week Low
  • OVID $0.24
  • GCV $3.15
  • 52 Week High
  • OVID $2.01
  • GCV $4.58
  • Technical
  • Relative Strength Index (RSI)
  • OVID 63.50
  • GCV 64.07
  • Support Level
  • OVID $1.24
  • GCV $4.00
  • Resistance Level
  • OVID $2.01
  • GCV $4.22
  • Average True Range (ATR)
  • OVID 0.20
  • GCV 0.07
  • MACD
  • OVID 0.03
  • GCV 0.01
  • Stochastic Oscillator
  • OVID 66.29
  • GCV 89.81

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About GCV Gabelli Convertible and Income Securities Fund Inc. (The)

GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.

Share on Social Networks: